There recently hasn't been much price action pre announcement. There was a lot of accumulation between this point and .10c a couple months ago util a CR caught people by surprise at 7c. Its finally nearing its way back to the previous levels.
- We are awaiting news on another 8 distribution partners (including majors) for both ViraDX and FebriDX
- CLIA Waivers for Febridx opening the product to 260,000 clinical settings
- Quarterly reporting at the end of the month
FOMO would be kicking in soon the longer it takes news to come and the short term gains from the CR are non existent.
